United Kingdom (UK) Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: June 23, 2025 Report Code: GDME0732MDB-ST

Select Item

GlobalData’s “United Kingdom Neurology Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Neurology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Neuromodulation Devices, Interventional Neuroradiology, Neurological Diagnostic and Monitoring Equipment, Radiosurgery Systems Neurosurgical Products, Hydrocephalus Shunts and Minimally Invasive Neurosurgery

The United Kingdom Neurology Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Neurology Devices Market.
• Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Neurology Devices is segmented as follows – _x000D_

• Neuromodulation Devices_x000D_

• Interventional Neuroradiology_x000D_

• Neurological Diagnostic and Monitoring Equipment_x000D_

• Radiosurgery Systems_x000D_

• Neurosurgical Products_x000D_

• Hydrocephalus Shunts_x000D_

• Minimally Invasive Neurosurgery

Reasons to Buy

The United Kingdom Neurology Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Medtronic Plc_x000D_
Boston Scientific Corp_x000D_
Stryker Corp_x000D_
Abbott Laboratories_x000D_
LivaNova PLC_x000D_
Nevro Corp_x000D_
Terumo Neuro_x000D_
Penumbra Inc_x000D_
Elekta AB_x000D_
Integra LifeSciences Corp_x000D_
Axonics Inc_x000D_
Natus Medical Inc_x000D_
Nihon Kohden Corp_x000D_
B. Braun Melsungen AG_x000D_
Cerenovus

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 8

2 Introduction 11

2.1 What Is This Report About? 11

2.2 Neurology Devices Market Segmentation 11

2.3 Definitions of Markets Covered in the Report 13

3 Neurology Devices Market, United Kingdom 20

3.1 Neurology Devices Market, United Kingdom, Revenue ($m), 2018-2033 20

3.2 Neurology Devices Market, United Kingdom, Revenue Mix ($m), 2023 22

3.3 Neurology Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2023 23

3.4 Neurology Devices Market, United Kingdom, Revenue ($m), 2018-2033 25

3.5 Neurology Devices Market, United Kingdom, Volume (Units), 2018-2033 27

3.6 Neurology Devices Market, United Kingdom, Volume (Units), 2018-2033 29

3.7 Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), 2023 32

4 Hydrocephalus Shunts Market, United Kingdom 34

4.1 Hydrocephalus Shunts Market, United Kingdom, Revenue Mix ($m), 2023 34

4.2 Hydrocephalus Shunts Market, United Kingdom, Segment Contribution (%), 2023 35

4.3 Hydrocephalus Shunts Market, United Kingdom, Revenue ($m), 2018-2033 37

4.3.1 Hydrocephalus Catheters Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 39

4.3.2 Hydrocephalus Valves Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 41

4.4 Hydrocephalus Shunts Market, United Kingdom, Volume (Units), 2018-2033 43

4.4.1 Hydrocephalus Catheters Market, United Kingdom, Volume (Units), by Segment, 2018-2033 45

4.4.2 Hydrocephalus Valves Market, United Kingdom, Volume (Units), by Segment, 2018-2033 47

4.5 Hydrocephalus Shunts Market, United Kingdom, Average Price ($), 2018-2033 49

4.6 Hydrocephalus Shunts Market, United Kingdom, Distribution Share by Revenue ($m), 2023 50

4.7 Hydrocephalus Shunts Market, United Kingdom, Company Share by Revenue ($m), 2023 51

5 Interventional Neuroradiology Market, United Kingdom 53

5.1 Interventional Neuroradiology Market, United Kingdom, Revenue Mix ($m), 2023 53

5.2 Interventional Neuroradiology Market, United Kingdom, Segment Contribution (%), 2023 54

5.3 Interventional Neuroradiology Market, United Kingdom, Revenue ($m), 2018-2033 56

5.3.1 Neurovascular Accessory Devices Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 58

5.3.2 Neurovascular Coiling Assist Devices Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 60

5.3.3 Neurovascular Embolization Devices Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 62

5.3.4 Neurovascular Thrombectomy Devices Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 64

5.4 Interventional Neuroradiology Market, United Kingdom, Volume (Units), 2018-2033 66

5.4.1 Neurovascular Accessory Devices Market, United Kingdom, Volume (Units), by Segment, 2018-2033 68

5.4.2 Neurovascular Coiling Assist Devices Market, United Kingdom, Volume (Units), by Segment, 2018-2033 70

5.4.3 Neurovascular Embolization Devices Market, United Kingdom, Volume (Units), by Segment, 2018-2033 72

5.4.4 Neurovascular Thrombectomy Devices Market, United Kingdom, Volume (Units), by Segment, 2018-2033 74

5.5 Interventional Neuroradiology Market, United Kingdom, Average Price ($) , 2018-2033 76

5.6 Interventional Neuroradiology Market, United Kingdom, Distribution Share by Revenue ($m), 2023 78

5.7 Interventional Neuroradiology Market, United Kingdom, Company Share by Revenue ($m), 2023 79

6 Minimally Invasive Neurosurgery Market, United Kingdom 81

6.1 Minimally Invasive Neurosurgery Market, United Kingdom, Revenue Mix ($m), 2023 81

6.2 Minimally Invasive Neurosurgery Market, United Kingdom, Segment Contribution (%), 2023 82

6.3 Minimally Invasive Neurosurgery Market, United Kingdom, Revenue ($m), 2018-2033 84

6.3.1 Minimally Invasive Neurosurgical Devices Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 86

6.4 Minimally Invasive Neurosurgery Market, United Kingdom, Volume (Units), 2018-2033 88

6.4.1 Minimally Invasive Neurosurgical Devices Market, United Kingdom, Volume (Units), by Segment, 2018-2033 90

6.5 Minimally Invasive Neurosurgery Market, United Kingdom, Average Price ($), 2018-2033 92

6.6 Minimally Invasive Neurosurgery Market, United Kingdom, Distribution Share by Revenue ($m), 2023 93

6.7 Minimally Invasive Neurosurgery Market, United Kingdom, Company Share by Revenue ($m), 2023 94

7 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom 96

7.1 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Revenue Mix ($m), 2023 96

7.2 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Segment Contribution (%), 2023 97

7.3 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Revenue ($m), 2018-2033 99

7.3.1 Electrical Activity Testing Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 101

7.3.2 ICP Monitoring Devices Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 103

7.4 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Volume (Units), 2018-2033 105

7.4.1 Electrical Activity Testing Market, United Kingdom, Volume (Units), by Segment, 2018-2033 107

7.4.2 ICP Monitoring Devices Market, United Kingdom, Volume (Units), by Segment, 2018-2033 109

7.5 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Average Price ($), 2018-2033 111

7.6 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Distribution Share by Revenue ($m), 2023 112

7.7 Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Company Share by Revenue ($m), 2023 113

8 Neuromodulation Devices Market, United Kingdom 115

8.1 Neuromodulation Devices Market, United Kingdom, Revenue Mix ($m), 2023 115

8.2 Neuromodulation Devices Market, United Kingdom, Segment Contribution (%), 2023 116

8.3 Neuromodulation Devices Market, United Kingdom, Revenue ($m), 2018-2033 118

8.3.1 Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 120

8.3.2 Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 122

8.3.3 Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 124

8.3.4 Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 126

8.3.5 Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 128

8.3.6 Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 130

8.4 Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033 132

8.4.1 Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033 134

8.4.2 Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), by Segment, 2018-2033 136

8.4.3 Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033 138

8.4.4 Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033 140

8.4.5 Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033 142

8.4.6 Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033 144

8.5 Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033 146

8.6 Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2023 149

8.7 Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2023 150

9 Neurosurgical Products Market, United Kingdom 152

9.1 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2023 152

9.2 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2023 153

9.3 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2018-2033 155

9.3.1 Dura Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 157

9.3.2 Neuroendoscopes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 159

9.3.3 Neurosurgical Drills Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 161

9.4 Neurosurgical Products Market, United Kingdom, Volume (Units), 2018-2033 163

9.4.1 Dura Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033 165

9.4.2 Neuroendoscopes Market, United Kingdom, Volume (Units), by Segment, 2018-2033 167

9.4.3 Neurosurgical Drills Market, United Kingdom, Volume (Units), by Segment, 2018-2033 169

9.5 Neurosurgical Products Market, United Kingdom, Average Price ($), 2018-2033 171

9.6 Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), 2023 173

9.7 Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), 2023 174

10 Radiosurgery Systems Market, United Kingdom 176

10.1 Radiosurgery Systems Market, United Kingdom, Revenue Mix ($m), 2023 176

10.2 Radiosurgery Systems Market, United Kingdom, Segment Contribution (%), 2023 177

10.3 Radiosurgery Systems Market, United Kingdom, Revenue ($m), 2018-2033 179

10.4 Radiosurgery Systems Market, United Kingdom, Volume (Units), 2018-2033 181

10.5 Radiosurgery Systems Market, United Kingdom, Average Price ($) , 2018-2033 183

10.6 Radiosurgery Systems Market, United Kingdom, Distribution Share by Revenue ($m), 2023 184

10.7 Radiosurgery Systems Market, United Kingdom, Company Share by Revenue ($m), 2023 185

11 Overview of Key Companies in United Kingdom, Neurology Devices Market 187

11.1 Medtronic Plc 187

11.1.1 Company Overview 187

11.2 Stryker Corp 187

11.2.1 Company Overview 187

11.3 LivaNova Plc 187

11.3.1 Company Overview 187

11.4 Integra LifeSciences Corp 187

11.4.1 Company Overview 187

11.5 Elekta AB 188

11.5.1 Company Overview 188

11.6 B. Braun Melsungen AG 188

11.6.1 Company Overview 188

11.7 Natus Medical Inc 188

11.7.1 Company Overview 188

11.8 Nihon Kohden Corp 188

11.8.1 Company Overview 188

11.9 Penumbra Inc 189

11.9.1 Company Overview 189

11.10 Terumo Neuro 189

11.10.1 Company Overview 189

11.11 Boston Scientific Corp 189

11.11.1 Company Overview 189

11.12 Abbott Laboratories 189

11.12.1 Company Overview 189

11.13 Varian Medical Systems Inc 190

11.13.1 Company Overview 190

11.14 Cerenovus 190

11.14.1 Company Overview 190

12 Neurology Devices Market Pipeline Products 191

13 Financial Deals Landscape 202

13.1 Acquisition 202

13.1.1 Spectra Medical Devices Acquires XL Precision Technologies from Rubicon Partners Industries 202

13.1.2 GBUK Group Acquires Severn Healthcare Technologies 204

13.2 Equity Offerings 205

13.2.1 IXICO Raises USD5.30 Million in Rights Offering of Shares 205

13.2.2 IXICO to Raise Additional USD0.06 Million in Rights Offering of Shares 207

13.2.3 Cambridge Cognition Holdings Raises Upto USD3.19 Million in Private Placement of Shares 208

13.2.4 Cambridge Cognition Holdings to Raise USD0.15 Million in Open Offer 210

13.3 Venture Financing 212

13.3.1 Mint Neurotechnologies (MintNeuro) Secures USD1.28 Million in Venture Financing 212

13.3.2 Amber Therapeutics Secures USD100 Million in Series A Venture Financing 214

13.3.3 Oxford Endovascular Raises USD10.16 Million in Series A+ Financing 216

14 Recent Developments 218

14.1 Corporate Communications 218

14.1.1 Nov 12, 2024: £1M to Advance Mintneuro’s Transformative Semiconductor Tech for Neural Implants 218

14.1.2 Oct 08, 2024: LivaNova Appoints Susan Podlogar as a New Director 218

14.1.3 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group 219

14.1.4 Aug 05, 2024: IXICO Announces Hiring of Bram Goorden as Chief Executive Officer 219

14.2 Financial Announcements 220

14.2.1 Nov 12, 2024: Oxford Instruments Announces Half-Year Results 220

14.2.2 Oct 30, 2024: LivaNova Announces Q3 2024 Results 221

14.2.3 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024 222

14.2.4 Sep 25, 2024: LivaNova to Announce Third-Quarter 2024 Results 223

14.2.5 Aug 22, 2024: Cambridge Cognition Holdings Reports Interim Results for Six-Month Period Ended June 30, 2024 223

14.2.6 Jun 11, 2024: Oxford Instruments Announces 2024 Annual Report and Accounts 223

14.3 Government and Public Interest 224

14.3.1 Aug 30, 2024: Brain Fluid Surgery: News from Imperial 224

14.4 Other Significant Developments 224

14.4.1 Dec 09, 2024: ‘Digital Twin Brain’ Tech for People With Parkinson’s Given Funding Green Light 224

14.4.2 Aug 15, 2024: NIH Funds UK’s Groundbreaking DBS-Plus Trial for Parkinson’s 225

14.4.3 Aug 14, 2024: IXICO : Long term contract win for a study in Huntington's Disease 226

14.4.4 May 24, 2024: iHealthScreen Developed and Validated Risk Prediction Models for Cardiovascular Diseases Using Individual’s Retinal Color Images and Health Data 226

14.4.5 Apr 30, 2024: Khalifa University, Mubadala And Kelix Bio Collaborate To Advance UAE’s Biopharma Capabilities 227

14.5 Product News 228

14.5.1 Feb 24, 2025: AI to Diagnose Invisible Brain Abnormalities in People With Epilepsy 228

14.5.2 Oct 31, 2024: Cambridge Cognition Addressing Inconsistencies in CNS Clinical Trials with Advanced Quality Review Solutions Presentation of new data demonstrates effectiveness of proprietary AQUA 229

14.5.3 Sep 12, 2024: Wearable Brain Imaging Device Sheds Light on How Babies Respond in Real-World Situations 229

14.5.4 Aug 19, 2024: Progress Towards A Form Of Adaptable Deep Brain Stimulation 230

14.5.5 Jul 16, 2024: NICE recommends digital technology to help diagnose ADHD in children and young people 230

14.5.6 Jun 26, 2024: First UK Trial of Deep Brain Stimulation for Children with Epilepsy Begins 231

14.5.7 Jun 12, 2024: MYndspan Announces New Study That Accurately Predicts Brain Age Across the Lifespan 232

14.5.8 May 09, 2024: ‘Wraparound’ Implants Represent New Approach to Treating Spinal Cord Injuries 233

14.6 Strategy And Business Planning 234

14.6.1 Feb 10, 2025: Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients 234

14.6.2 Feb 03, 2025: MYndspan and BIOS Health Announce Partnership 234

14.6.3 Jan 10, 2025: Imaging Biometrics and Prism Clinical Imaging Secure First Installation 235

14.6.4 Nov 13, 2024: VIVOLTA Signs Long-Term Partnership With Neurochase 235

14.6.5 Oct 28, 2024: Collaborative Effort to Conduct a Study Aimed at Improving the Diagnosis of Alzheimer’s and Related Dementias for Everyone 236

14.6.6 Aug 08, 2024: Mint, Amber and GOLD – Spinouts Colour the Future of Neural Implants 237

14.6.7 Jul 29, 2024: A.Menarini, CARiNG Pharmacy and ACT4Health Join Forces to Drive Mild Cognitive Impairment Early Detection with a Free Visual Cognitive Assessment Test 238

14.6.8 Jun 17, 2024: Brain+ establishes UK subsidiary 240

14.6.9 May 21, 2024: MYndspan Becomes the First Company in the World to Offer MEG Brain Health Scans Directly to Consumers 240

15 Appendix 242

15.1 Research Methodology 243

15.1.1 Coverage 243

15.1.2 Secondary Research 243

15.1.3 Primary Research 244

15.1.4 Market Modeling and Forecasting 245

15.1.5 Company Share Analysis 246

15.1.6 Distribution Share Analysis 246

15.1.7 Benchmarking 247

15.2 GlobalData Consulting 247

15.3 Contact Us 247

15.4 Disclaimer 248

Table

Table 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 21

Table 2: Neurology Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2023 24

Table 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 26

Table 4: Neurology Devices Market, United Kingdom, Volume (Units), 2018-2033 28

Table 5: Neurology Devices Market, United Kingdom, Volume (Units), 2018-2033 30

Table 6: Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 33

Table 7: Hydrocephalus Shunts Market, United Kingdom, Segment Contribution (%), 2023 36

Table 8: Hydrocephalus Shunts Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 38

Table 9: Hydrocephalus Catheters Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 40

Table 10: Hydrocephalus Valves Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 42

Table 11: Hydrocephalus Shunts Market, United Kingdom, Volume (Units), 2018-2033 44

Table 12: Hydrocephalus Catheters Market, United Kingdom, Volume (Units), 2018-2033 46

Table 13: Hydrocephalus Valves Market, United Kingdom, Volume (Units), 2018-2033 48

Table 14: Hydrocephalus Shunts Market, United Kingdom, Average Price ($), 2018-2033 49

Table 15: Hydrocephalus Shunts Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 50

Table 16: Hydrocephalus Shunts Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 52

Table 17: Interventional Neuroradiology Market, United Kingdom, Segment Contribution (%), 2023 55

Table 18: Interventional Neuroradiology Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 57

Table 19: Neurovascular Accessory Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 59

Table 20: Neurovascular Coiling Assist Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 61

Table 21: Neurovascular Embolization Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 63

Table 22: Neurovascular Thrombectomy Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 65

Table 23: Interventional Neuroradiology Market, United Kingdom, Volume (Units), 2018-2033 67

Table 24: Neurovascular Accessory Devices Market, United Kingdom, Volume (Units), 2018-2033 69

Table 25: Neurovascular Coiling Assist Devices Market, United Kingdom, Volume (Units), 2018-2033 71

Table 26: Neurovascular Embolization Devices Market, United Kingdom, Volume (Units), 2018-2033 73

Table 27: Neurovascular Thrombectomy Devices Market, United Kingdom, Volume (Units), 2018-2033 75

Table 28: Interventional Neuroradiology Market, United Kingdom, Average Price ($), 2018-2033 76

Table 29: Interventional Neuroradiology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 78

Table 30: Interventional Neuroradiology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 80

Table 31: Minimally Invasive Neurosurgery Market, United Kingdom, Segment Contribution (%), 2023 83

Table 32: Minimally Invasive Neurosurgery Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 85

Table 33: Minimally Invasive Neurosurgical Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 87

Table 34: Minimally Invasive Neurosurgery Market, United Kingdom, Volume (Units), 2018-2033 89

Table 35: Minimally Invasive Neurosurgical Devices Market, United Kingdom, Volume (Units), 2018-2033 91

Table 36: Minimally Invasive Neurosurgery Market, United Kingdom, Average Price ($), 2018-2033 92

Table 37: Minimally Invasive Neurosurgery Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 93

Table 38: Minimally Invasive Neurosurgery Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 95

Table 39: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Segment Contribution (%), 2023 98

Table 40: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 100

Table 41: Electrical Activity Testing Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 102

Table 42: ICP Monitoring Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 104

Table 43: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Volume (Units), 2018-2033 106

Table 44: Electrical Activity Testing Market, United Kingdom, Volume (Units), 2018-2033 108

Table 45: ICP Monitoring Devices Market, United Kingdom, Volume (Units), 2018-2033 110

Table 46: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Average Price ($), 2018-2033 111

Table 47: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 112

Table 48: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 114

Table 49: Neuromodulation Devices Market, United Kingdom, Segment Contribution (%), 2023 117

Table 50: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 119

Table 51: Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 121

Table 52: Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 123

Table 53: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 125

Table 54: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 127

Table 55: Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 129

Table 56: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 131

Table 57: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033 133

Table 58: Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), 2018-2033 135

Table 59: Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), 2018-2033 137

Table 60: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), 2018-2033 139

Table 61: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), 2018-2033 141

Table 62: Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), 2018-2033 143

Table 63: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), 2018-2033 145

Table 64: Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033 146

Table 65: Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 149

Table 66: Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 151

Table 67: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2023 154

Table 68: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 156

Table 69: Dura Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 158

Table 70: Neuroendoscopes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 160

Table 71: Neurosurgical Drills Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 162

Table 72: Neurosurgical Products Market, United Kingdom, Volume (Units), 2018-2033 164

Table 73: Dura Substitutes Market, United Kingdom, Volume (Units), 2018-2033 166

Table 74: Neuroendoscopes Market, United Kingdom, Volume (Units), 2018-2033 168

Table 75: Neurosurgical Drills Market, United Kingdom, Volume (Units), 2018-2033 170

Table 76: Neurosurgical Products Market, United Kingdom, Average Price ($), 2018-2033 171

Table 77: Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 173

Table 78: Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 175

Table 79: Radiosurgery Systems Market, United Kingdom, Segment Contribution (%), 2023 178

Table 80: Radiosurgery Systems Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 180

Table 81: Radiosurgery Systems Market, United Kingdom, Volume (Units), 2018-2033 182

Table 82: Radiosurgery Systems Market, United Kingdom, Average Price ($), 2018-2033 183

Table 83: Radiosurgery Systems Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 184

Table 84: Radiosurgery Systems Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 186

Table 85: Neurology Devices Market Pipeline Products 191

Table 86: Spectra Medical Devices Acquires XL Precision Technologies from Rubicon Partners Industries 202

Table 87: GBUK Group Acquires Severn Healthcare Technologies 204

Table 88: IXICO Raises USD5.30 Million in Rights Offering of Shares 205

Table 89: IXICO to Raise Additional USD0.06 Million in Rights Offering of Shares 207

Table 90: Cambridge Cognition Holdings Raises Upto USD3.19 Million in Private Placement of Shares 208

Table 91: Cambridge Cognition Holdings to Raise USD0.15 Million in Open Offer 210

Table 92: Mint Neurotechnologies (MintNeuro) Secures USD1.28 Million in Venture Financing 212

Table 93: Amber Therapeutics Secures USD100 Million in Series A Venture Financing 214

Table 94: Oxford Endovascular Raises USD10.16 Million in Series A+ Financing 216

Table 95: Total Number of Primary Research Participants, Neurology Devices Market, by Country 244

Figures

Figure 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 20

Figure 2: Neurology Devices Market, United Kingdom, Revenue Mix ($m), 2023 22

Figure 3: Neurology Devices Market, United Kingdom, Category Contribution (%), 2023 23

Figure 4: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 25

Figure 5: Neurology Devices Market, United Kingdom, Volume (Units), 2018-2033 27

Figure 6: Neurology Devices Market, United Kingdom, Volume (Units), 2018-2033 29

Figure 7: Neurology Devices Market, United Kingdom, Company Share (%) 2023 32

Figure 8: Hydrocephalus Shunts Market, United Kingdom, Revenue Mix ($m), 2023 34

Figure 9: Hydrocephalus Shunts Market, United Kingdom, Segment Contribution (%), 2023 35

Figure 10: Hydrocephalus Shunts Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 37

Figure 11: Hydrocephalus Catheters Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 39

Figure 12: Hydrocephalus Valves Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 41

Figure 13: Hydrocephalus Shunts Market, United Kingdom, Volume (Units), 2018-2033 43

Figure 14: Hydrocephalus Catheters Market, United Kingdom, Volume (Units), 2018-2033 45

Figure 15: Hydrocephalus Valves Market, United Kingdom, Volume (Units), 2018-2033 47

Figure 16: Hydrocephalus Shunts Market, United Kingdom, Company Share (%) 2023 51

Figure 17: Interventional Neuroradiology Market, United Kingdom, Revenue Mix ($m), 2023 53

Figure 18: Interventional Neuroradiology Market, United Kingdom, Segment Contribution (%), 2023 54

Figure 19: Interventional Neuroradiology Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 56

Figure 20: Neurovascular Accessory Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 58

Figure 21: Neurovascular Coiling Assist Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 60

Figure 22: Neurovascular Embolization Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 62

Figure 23: Neurovascular Thrombectomy Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 64

Figure 24: Interventional Neuroradiology Market, United Kingdom, Volume (Units), 2018-2033 66

Figure 25: Neurovascular Accessory Devices Market, United Kingdom, Volume (Units), 2018-2033 68

Figure 26: Neurovascular Coiling Assist Devices Market, United Kingdom, Volume (Units), 2018-2033 70

Figure 27: Neurovascular Embolization Devices Market, United Kingdom, Volume (Units), 2018-2033 72

Figure 28: Neurovascular Thrombectomy Devices Market, United Kingdom, Volume (Units), 2018-2033 74

Figure 29: Interventional Neuroradiology Market, United Kingdom, Company Share (%) 2023 79

Figure 30: Minimally Invasive Neurosurgery Market, United Kingdom, Revenue Mix ($m), 2023 81

Figure 31: Minimally Invasive Neurosurgery Market, United Kingdom, Segment Contribution (%), 2023 82

Figure 32: Minimally Invasive Neurosurgery Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 84

Figure 33: Minimally Invasive Neurosurgical Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 86

Figure 34: Minimally Invasive Neurosurgery Market, United Kingdom, Volume (Units), 2018-2033 88

Figure 35: Minimally Invasive Neurosurgical Devices Market, United Kingdom, Volume (Units), 2018-2033 90

Figure 36: Minimally Invasive Neurosurgery Market, United Kingdom, Company Share (%) 2023 94

Figure 37: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Revenue Mix ($m), 2023 96

Figure 38: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Segment Contribution (%), 2023 97

Figure 39: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 99

Figure 40: Electrical Activity Testing Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 101

Figure 41: ICP Monitoring Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 103

Figure 42: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Volume (Units), 2018-2033 105

Figure 43: Electrical Activity Testing Market, United Kingdom, Volume (Units), 2018-2033 107

Figure 44: ICP Monitoring Devices Market, United Kingdom, Volume (Units), 2018-2033 109

Figure 45: Neurological Diagnostic and Monitoring Equipment Market, United Kingdom, Company Share (%) 2023 113

Figure 46: Neuromodulation Devices Market, United Kingdom, Revenue Mix ($m), 2023 115

Figure 47: Neuromodulation Devices Market, United Kingdom, Segment Contribution (%), 2023 116

Figure 48: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 118

Figure 49: Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 120

Figure 50: Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 122

Figure 51: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 124

Figure 52: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 126

Figure 53: Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 128

Figure 54: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 130

Figure 55: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033 132

Figure 56: Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), 2018-2033 134

Figure 57: Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), 2018-2033 136

Figure 58: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), 2018-2033 138

Figure 59: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), 2018-2033 140

Figure 60: Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), 2018-2033 142

Figure 61: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), 2018-2033 144

Figure 62: Neuromodulation Devices Market, United Kingdom, Company Share (%) 2023 150

Figure 63: Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2023 152

Figure 64: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2023 153

Figure 65: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 155

Figure 66: Dura Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 157

Figure 67: Neuroendoscopes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 159

Figure 68: Neurosurgical Drills Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 161

Figure 69: Neurosurgical Products Market, United Kingdom, Volume (Units), 2018-2033 163

Figure 70: Dura Substitutes Market, United Kingdom, Volume (Units), 2018-2033 165

Figure 71: Neuroendoscopes Market, United Kingdom, Volume (Units), 2018-2033 167

Figure 72: Neurosurgical Drills Market, United Kingdom, Volume (Units), 2018-2033 169

Figure 73: Neurosurgical Products Market, United Kingdom, Company Share (%) 2023 174

Figure 74: Radiosurgery Systems Market, United Kingdom, Revenue Mix ($m), 2023 176

Figure 75: Radiosurgery Systems Market, United Kingdom, Segment Contribution (%), 2023 177

Figure 76: Radiosurgery Systems Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 179

Figure 77: Radiosurgery Systems Market, United Kingdom, Volume (Units), 2018-2033 181

Figure 78: Radiosurgery Systems Market, United Kingdom, Company Share (%) 2023 185

United Kingdom (UK) Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports
Medical Devices
New
Adult Feeding Tubes and Formula Market Size by Segments, Share,…
$7,500 | October 2026
Medical Devices
New
Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | October 2026
Medical Devices
New
Body Contouring Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | October 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United Kingdom (UK) Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others in real time.

  • Access a live United Kingdom (UK) Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more